BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 14508188)

  • 1. Blood pressure is insufficiently controlled in European patients with established coronary heart disease.
    Boersma E; Keil U; De Bacquer D; De Backer G; Pyörälä K; Poldermans D; Leprotti C; Pilotto L; de Swart E; Deckers JW; Heidrich J; Sans S; Kotseva K; Wood D; Ambrosio GB;
    J Hypertens; 2003 Oct; 21(10):1831-40. PubMed ID: 14508188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. EUROASPIRE Study Group. European Action on Secondary Prevention through Intervention to Reduce Events.
    Eur Heart J; 1997 Oct; 18(10):1569-82. PubMed ID: 9347267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events.
    EUROASPIRE I and II Group; European Action on Secondary Prevention by Intervention to Reduce Events
    Lancet; 2001 Mar; 357(9261):995-1001. PubMed ID: 11293642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme.
    EUROASPIRE II Study Group
    Eur Heart J; 2001 Apr; 22(7):554-72. PubMed ID: 11259143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time Trends in Lifestyle, Risk Factor Control, and Use of Evidence-Based Medications in Patients With Coronary Heart Disease in Europe: Results From 3 EUROASPIRE Surveys, 1999-2013.
    Kotseva K; De Bacquer D; Jennings C; Gyberg V; De Backer G; Rydén L; Amouyel P; Bruthans J; Cifkova R; Deckers JW; De Sutter J; Fraz Z; Graham I; Keber I; Lehto S; Moore D; Pajak A; Wood D;
    Glob Heart; 2017 Dec; 12(4):315-322.e3. PubMed ID: 26994643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries.
    Kotseva K; Wood D; De Bacquer D; De Backer G; Rydén L; Jennings C; Gyberg V; Amouyel P; Bruthans J; Castro Conde A; Cífková R; Deckers JW; De Sutter J; Dilic M; Dolzhenko M; Erglis A; Fras Z; Gaita D; Gotcheva N; Goudevenos J; Heuschmann P; Laucevicius A; Lehto S; Lovic D; Miličić D; Moore D; Nicolaides E; Oganov R; Pajak A; Pogosova N; Reiner Z; Stagmo M; Störk S; Tokgözoğlu L; Vulic D;
    Eur J Prev Cardiol; 2016 Apr; 23(6):636-48. PubMed ID: 25687109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood pressure control and knowledge of target blood pressure in coronary patients across Europe: results from the EUROASPIRE III survey.
    Prugger C; Keil U; Wellmann J; de Bacquer D; de Backer G; Ambrosio GB; Reiner Z; Gaita D; Wood D; Kotseva K; Heidrich J;
    J Hypertens; 2011 Aug; 29(8):1641-8. PubMed ID: 21720270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries.
    Kotseva K; Wood D; De Backer G; De Bacquer D; Pyörälä K; Keil U;
    Lancet; 2009 Mar; 373(9667):929-40. PubMed ID: 19286092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Secondary prevention of coronary heart disease. Results from EuroASPIRE I and II in the region of Münster, Germany].
    Heidrich J; Liese AD; Kalic M; Winter-Enbergs A; Wellmann J; Roeder N; Kerber S; Breithardt G; Scheld HH; Kleine-Katthöfer P; Keil U
    Dtsch Med Wochenschr; 2002 Mar; 127(13):667-72. PubMed ID: 11928058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smoking behaviour in European patients with established coronary heart disease.
    Scholte op Reimer W; de Swart E; De Bacquer D; Pyörälä K; Keil U; Heidrich J; Deckers JW; Kotseva K; Wood D; Boersma E
    Eur Heart J; 2006 Jan; 27(1):35-41. PubMed ID: 16210309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [EUROASPIRE: survey conducted by the European Society of Cardiology on secondary prevention of coronary disease. Hungarian results].
    Ostör E; Jánosi A; Belatiny KA; Borbás S; Bradak A; Podmaniczky M
    Orv Hetil; 1999 Jan; 140(5):243-8. PubMed ID: 10064978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential for cholesterol lowering in secondary prevention of coronary heart disease in europe: findings from EUROASPIRE study. European Action on Secondary Prevention through Intervention to Reduce Events.
    Vanuzzo D; Pilotto L; Ambrosio GB; Pyörälä K; Lehto S; De Bacquer D; De Backer G; Wood D;
    Atherosclerosis; 2000 Dec; 153(2):505-17. PubMed ID: 11164441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factor management in diabetic and non-diabetic patients with coronary heart disease. Findings from the EUROASPIRE I AND II surveys.
    Pyörälä K; Lehto S; De Bacquer D; De Sutter J; Sans S; Keil U; Wood D; De Backer G;
    Diabetologia; 2004 Jul; 47(7):1257-1265. PubMed ID: 15235774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries.
    Kotseva K; Wood D; De Backer G; De Bacquer D; Pyörälä K; Keil U;
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):121-37. PubMed ID: 19287307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in secondary prevention of coronary artery disease in the post-discharge period over the decade 1997-2007. Results of the Cracovian Program for Secondary Prevention of Ischaemic Heart Disease and Polish parts of the EUROASPIRE II and III surveys.
    Pajak A; Jankowski P; Kawecka-Jaszcz K; Surowiec S; Wolfshaut R; Loster M; Batko K; Badacz L; Dubiel JS; Grodecki J; Grodzicki T; Maciejewicz J; Mirek-Bryniarska E; Piotrowski W; Smielak-Korombel W; Tracz W
    Kardiol Pol; 2009 Dec; 67(12):1353-9. PubMed ID: 20054766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Secondary prevention of coronary disease--at the turn of the millennium in light of the Hungarian data of the EUROASPIRE I-II. Studies].
    Ostör E; Jánosi A; Adám Z; Bárczy G; Borbás S; Dávid B; Gallai I; Podmaniczky M; Ruzsányi T
    Orv Hetil; 2003 Dec; 144(49):2399-404. PubMed ID: 14725205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lifestyle behaviour and risk factor control in coronary patients: Belgian results from the cross-sectional EUROASPIRE surveys.
    De Smedt D; De Sutter J; De Pauw M; Vandekerckhove H; Trouerbach J; De Backer G; Willems AM; Pardaens S; Vervaet P; Deweerdt N; De Bacquer D
    Acta Cardiol; 2019 Feb; 74(1):21-27. PubMed ID: 29458303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of main risk factors after ischaemic stroke across Europe: data from the stroke-specific module of the EUROASPIRE III survey.
    Heuschmann PU; Kircher J; Nowe T; Dittrich R; Reiner Z; Cifkova R; Malojcic B; Mayer O; Bruthans J; Wloch-Kopec D; Prugger C; Heidrich J; Keil U
    Eur J Prev Cardiol; 2015 Oct; 22(10):1354-62. PubMed ID: 25139770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pursuit of secondary prevention targets in Czech coronary patients. A comparison of EuroAspire I and II surveys.
    Mayer O; Simon J; Rosolová H; De Bacquer D;
    Cent Eur J Public Health; 2002 Sep; 10(3):107-11. PubMed ID: 12298341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study).
    Reiner Z; Mihatov S; Milicić D; Bergovec M; Planinc D;
    Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):646-54. PubMed ID: 16874158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.